Moderna, Inc (MRNA) News Headlines

▮ More

Date

Headline

6/4/2020 12:37:03 AM List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps On MISSION

6/1/2020 6:05:11 AM Stock Alert: Moderna Shares Up 4% In Premarket

5/28/2020 8:00:00 AM Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity (Press Release)

5/28/2020 1:48:04 AM CordenPharma, Moderna Extend Deal For Lipid Excipients To Be Used In Vaccine Against Coronavirus

5/28/2020 1:33:45 AM CordenPharma, Moderna Extend Manufacturing Services Deal For Supply Of Lipid Excipients To Be Used In MRNA-1273

5/24/2020 3:45:31 AM The Week That Was: COVID-19 Drug/Vaccine Development Landscape

5/19/2020 4:18:12 AM Stock Alert: Moderna In The Limelight; Uptrend Continues

5/18/2020 11:23:34 PM Moderna Prices Public Offering Of 17.60 Mln Shares At $76.00/shr

5/18/2020 10:04:13 PM ABUS Up On HBV Trial Data, VIR's COVID-19 Therapies On Track, All Eyes On DVAX

5/18/2020 5:47:26 PM Moderna To Sell $1.25 Bln Shares After Positive News On COVID-19 Vaccine

5/18/2020 10:09:41 AM Stock Alert: Moderna Jumps 19% On Positive News On Its Vaccine

5/18/2020 7:33:32 AM Moderna Announces Positive Interim Phase 1 Data For MRNA Vaccine Against Novel Coronavirus

5/13/2020 12:21:54 AM ARPO Soars, GNFT's NASH Study Fails, Moderna's COVID-19 Vaccine On Fast Track

5/12/2020 5:39:06 PM Moderna's Coronavirus Vaccine Candidate Gets Fast Track Designation

5/12/2020 8:05:35 AM Moderna Receives FDA Fast Track Designation For MRNA-1273 Against Novel Coronavirus

5/1/2020 1:10:31 AM Moderna, Lonza In Deal To Manufacture MRNA-1273 Vaccine Against Coronavirus

5/1/2020 12:53:31 AM Moderna, Lonza Announce Strategic Collaboration To Manufacture Moderna's MRNA-1273 Against Novel Coronavirus

4/30/2020 8:58:48 PM Shot Roster: COVID-19 Vaccines In Human Trials

4/17/2020 7:11:20 AM Stock Alert: Moderna Shares Up 21% In Pre Market

4/16/2020 8:52:43 PM Moderna Gets BARDA Award For $483 Mln To Speed Up COVID-19 Vaccine Development